Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Clinical trial NCT00665470 · COMPLETED

Trial details

NCT number: NCT00665470
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin Cancer Metastatic Melanoma

Start date: 2008-04-01
Primary completion: 2012-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.